David H. Kerman

1.3k total citations
48 papers, 478 citations indexed

About

David H. Kerman is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, David H. Kerman has authored 48 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 22 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in David H. Kerman's work include Inflammatory Bowel Disease (26 papers), Microscopic Colitis (20 papers) and Gut microbiota and health (6 papers). David H. Kerman is often cited by papers focused on Inflammatory Bowel Disease (26 papers), Microscopic Colitis (20 papers) and Gut microbiota and health (6 papers). David H. Kerman collaborates with scholars based in United States. David H. Kerman's co-authors include Amar R. Deshpande, María T. Abreu, Maria A. Quintero, Oriana M. Damas, Irina Fernández, Juan F. Burgueño, Judith Pignac-Kobinger, Stephen M. Katz, Ronald H. Kerman and Yuguang Ban and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

David H. Kerman

41 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David H. Kerman United States 10 151 143 130 94 94 48 478
Antoine Petitcollin France 16 98 0.6× 108 0.8× 115 0.9× 38 0.4× 157 1.7× 25 575
Luciano M. Vargas United States 8 82 0.5× 178 1.2× 67 0.5× 32 0.3× 69 0.7× 29 413
Justyna Gołębiewska Poland 13 37 0.2× 109 0.8× 40 0.3× 84 0.9× 67 0.7× 39 437
Lynda Bererhi France 8 27 0.2× 57 0.4× 162 1.2× 32 0.3× 76 0.8× 13 381
Clifford D. Miles United States 13 53 0.4× 249 1.7× 61 0.5× 15 0.2× 309 3.3× 30 558
Anand Joshi India 12 91 0.6× 222 1.6× 122 0.9× 24 0.3× 44 0.5× 48 462
Yael Mozer‐Glassberg Israel 14 179 1.2× 211 1.5× 73 0.6× 13 0.1× 24 0.3× 42 555
Laura J. Wozniak United States 15 29 0.2× 413 2.9× 34 0.3× 87 0.9× 281 3.0× 42 745
Suporn Treepongkaruna Thailand 13 59 0.4× 264 1.8× 59 0.5× 41 0.4× 8 0.1× 87 632
Marlena Habal United States 13 14 0.1× 168 1.2× 215 1.7× 30 0.3× 69 0.7× 33 530

Countries citing papers authored by David H. Kerman

Since Specialization
Citations

This map shows the geographic impact of David H. Kerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Kerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Kerman more than expected).

Fields of papers citing papers by David H. Kerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Kerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Kerman. The network helps show where David H. Kerman may publish in the future.

Co-authorship network of co-authors of David H. Kerman

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Kerman. A scholar is included among the top collaborators of David H. Kerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Kerman. David H. Kerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Damas, Oriana M., Michael C. Leo, Irina Fernández, et al.. (2025). A Pilot Randomized Control Trial to Assess the Adjunctive Effect of Diet on Response to Advanced Therapies in Patients With Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 23(13). 2579–2587.e2.
2.
Fernández, Irina, Ana M. Santander, Maria A. Quintero, et al.. (2025). Deep Sequencing of Crohn’s Disease Lamina Propria Phagocytes Identifies Pathobionts and Correlates With Pro-Inflammatory Gene Expression. Inflammatory Bowel Diseases. 31(5). 1203–1219.
3.
Khakoo, Nidah S., Ashley Beecham, Maria A. Quintero, et al.. (2024). Early Life and Childhood Environmental Exposures, More Than Genetic Predisposition, Influence Age of Diagnosis in a Diverse Cohort of 2952 Patients With IBD. Clinical Gastroenterology and Hepatology. 22(7). 1462–1474.e5. 4 indexed citations
4.
Chi, Xiaofei, Matthew J. Gurka, Jaclyn Hall, et al.. (2024). Healthcare Utilization and Geographic Distribution of Advanced Therapy in Minority Race and Ethnic Groups With Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 31(2). 344–350.
5.
Chi, Xiaofei, Matthew J. Gurka, Stephanie L. Filipp, et al.. (2023). Healthcare Utilization Patterns and Excessive Steroid Use in Late Adolescence Age and Young Adults With Crohn’s Disease and Ulcerative Colitis. SHILAP Revista de lepidopterología. 2(7). 928–934. 1 indexed citations
6.
Fernández, Irina, Maria A. Quintero, Ana M. Santander, et al.. (2022). Lamina Propria Phagocyte Profiling Reveals Targetable Signaling Pathways in Refractory Inflammatory Bowel Disease. SHILAP Revista de lepidopterología. 1(3). 380–392. 6 indexed citations
7.
Huerta, Carlos Theodore, et al.. (2022). Small Intestinal Perforation Secondary to Necrotizing Enteritis—An Under-Recognized Complication of Crohn’s Disease. The American Surgeon. 89(5). 1997–2004. 2 indexed citations
8.
Mantero, Alejandro, Judith Pignac-Kobinger, Ana M. Santander, et al.. (2022). Combining Pentoxifylline With Vedolizumab for Crohn’s Disease: Results of a Randomised, Placebo-controlled Pilot Study. Journal of Crohn s and Colitis. 16(11). 1687–1695. 1 indexed citations
9.
Deshpande, Amar R., et al.. (2020). Assurance for Endurance? Introducing a Novel Ergonomics Curriculum to Reduce Pain and Enhance Physical Well-Being Among GI Fellows. Digestive Diseases and Sciences. 65(10). 2756–2758. 8 indexed citations
10.
Beecham, Ashley, Lissette Gomez, Maria A. Quintero, et al.. (2020). S0730 TPMT and NUDT15 Pharmacogenetics in a Diverse Hispanic IBD Population. The American Journal of Gastroenterology. 115(1). S366–S367.
11.
Damas, Oriana M., et al.. (2020). S0895 Is Two Better Than One? Combination Therapy With Vedolizumab and Tofacitinib for the Treatment of Patients With Inflammatory Bowel Disease. The American Journal of Gastroenterology. 115(1). S460–S461. 3 indexed citations
12.
Dheer, Rishu, Julie Davies, Maria A. Quintero, et al.. (2019). Microbial Signatures and Innate Immune Gene Expression in Lamina Propria Phagocytes of Inflammatory Bowel Disease Patients. Cellular and Molecular Gastroenterology and Hepatology. 9(3). 387–402. 25 indexed citations
13.
García-Buitrago, Mónica, et al.. (2018). P013 APOPTOTIC ENTEROPATHY INDUCED BY THALIDOMIDE IN A PATIENT WITH REFRACTORY UPPER AND COLONIC CROHNS’ DISEASE. Gastroenterology. 154(1). S7–S8.
14.
Damas, Oriana M., Lissette Gomez, Maria A. Quintero, et al.. (2017). Genetic Characterization and Influence on Inflammatory Bowel Disease Expression in a Diverse Hispanic South Florida Cohort. Clinical and Translational Gastroenterology. 8(4). e87–e87. 9 indexed citations
15.
Kerman, David H.. (2016). Endoscopic Delivery of Fecal Biotherapy in Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America. 26(4). 707–717. 6 indexed citations
16.
Kerman, David H. & Amar R. Deshpande. (2014). Gut Microbiota and Inflammatory Bowel Disease: The Role of Antibiotics in Disease Management. Postgraduate Medicine. 126(4). 7–19. 31 indexed citations
17.
Yarur, Andrés, Frank Czul, Amar R. Deshpande, et al.. (2013). Predictive factors for clinically actionable computed tomography findings in inflammatory bowel disease patients seen in the emergency department with acute gastrointestinal symptoms. Journal of Crohn s and Colitis. 8(6). 504–512. 26 indexed citations
18.
Yarur, Andrés, et al.. (2012). Recurrent Severe Dysphagia Secondary to a Siliconoma after Breast Implant Failure. The American Journal of Gastroenterology. 107. S262–S262. 1 indexed citations
19.
Kerman, Ronald H., B. Süßkind, David H. Kerman, et al.. (1997). Anti-HLA antibodies detected in posttransplant renal allograft recipient sera correlate with chronic rejection. Transplantation Proceedings. 29(1-2). 1515–1516. 27 indexed citations
20.
Kerman, Ronald H., Roland Buelow, Philippe Pouletty, et al.. (1996). CORRELATION OF ELISA-DETECTED IgG AND IgA ANTI-HLA ANTIBODIES IN PRETRANSPLANT SERA WITH RENAL ALLOGRAFT REJECTION1. Transplantation. 62(2). 201–205. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antoine Petitcollin Breakdown of academic impact, for papers by Luciano M. Vargas Breakdown of academic impact, for papers by Justyna Gołębiewska Breakdown of academic impact, for papers by Lynda Bererhi Breakdown of academic impact, for papers by Clifford D. Miles Breakdown of academic impact, for papers by Anand Joshi Breakdown of academic impact, for papers by Yael Mozer‐Glassberg Breakdown of academic impact, for papers by Laura J. Wozniak Breakdown of academic impact, for papers by Suporn Treepongkaruna Breakdown of academic impact, for papers by Marlena Habal
Rankless by CCL
2026